BMJ Best Practice

参考文献

关键文献

Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2016 Jan;26(1):1-133.

Wells SA Jr, Asa SL, Dralle H, et al. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid. 2015 Jun;25(6):567-610.

Francis GL, Waguespack SG, Bauer AJ, et al. Management guidelines for children with thyroid nodules and differentiated thyroid cancer. Thyroid. 2015 Jul;25(7):716-59.

参考文章

1.  Mevawalla N, McMullen T, Sidhu S, et al. Presentation of clinically solitary thyroid nodules in surgical patients. Thyroid. 2011 Jan;21(1):55-9.

2.  Mazzaferri EL. Management of a solitary thyroid nodule. N Engl J Med. 1993 Feb 25;328(8):553-9.

3.  Papini E, Guglielmi R, Bianchini A, et al. Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features. J Clin Endocrinol Metab. 2002 May;87(5):1941-6.

4.  Nam-Goong IS, Kim HY, Gong G, et al. Ultrasonography-guided fine-needle aspiration of thyroid incidentaloma: correlation with pathological findings. Clin Endocrinol (Oxf). 2004 Jan;60(1):21-8.

5.  Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2016 Jan;26(1):1-133.

6.  Ito Y, Miyauchi A, Oda H. Low-risk papillary microcarcinoma of the thyroid: a review of active surveillance trials. Eur J Surg Oncol. 2018 Mar;44(3):307-15.

7.  Brito JP, Ito Y, Miyauchi A, et al. A clinical framework to facilitate risk stratification when considering an active surveillance alternative to immediate biopsy and surgery in papillary microcarcinoma. Thyroid. 2016 Jan;26(1):144-9.

8.  Miyauchi A. Active surveillance of low-risk papillary microcarcinoma of the thyroid: Kuma hospital protocols and its outcomes. Video Endocrinology. 14 September 2016 [internet publication].

9.  Trülzsch B, Krohn K, Wonerow P, et al. Detection of thyroid-stimulating hormone receptor and Gsalpha mutations: in 75 toxic thyroid nodules by denaturing gradient gel electrophoresis. J Mol Med (Berl). 2001;78(12):684-91.

10.  Hundahl SA, Fleming ID, Fremgen AM, et al. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995. Cancer. 1998 Dec 15;83(12):2638-48.

11.  Wells SA Jr, Asa SL, Dralle H, et al. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid. 2015 Jun;25(6):567-610.

12.  Waguespack SG, Rich TA, Perrier ND, et al. Management of medullary thyroid carcinoma and MEN2 syndromes in childhood. Nat Rev Endocrinol. 2011 Aug 23;7(10):596-607.

13.  Smallridge RC, Ain KB, Asa SL, et al. American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer. Thyroid. 2012 Nov;22(11):1104-39.

14.  Pedersen RK, Pedersen NT. Primary non-Hodgkin's lymphoma of the thyroid gland: a population based study. Histopathology. 1996 Jan;28(1):25-32.

15.  de los Santos ET, Keyhani-Rofagha S, Cunningham JJ, et al. Cystic thyroid nodules: the dilemma of malignant lesions. Arch Intern Med. 1990 Jul;150(7):1422-7.

16.  Bhargava P, Parisi M. Infected thyroglossal duct cyst. Pediatr Radiol. 2010 Dec;40 (Suppl 1):S84.

17.  Lucaya J, Berdon WE, Enriquez G, et al. Congenital pyriform sinus fistula: a cause of acute left-sided suppurative thyroiditis and neck abscess in children. Pediatr Radiol. 1990;21(1):27-9.

18.  Vanderpump MP, Tunbridge WM, French JM, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham survey. Clin Endocrinol (Oxf). 1995 Jul;43(1):55-68.

19.  Rothman IN, Middleton L, Stack BC Jr, et al. Incidence of diffuse FDG uptake in the thyroid of patients with hypothyroidism. Eur Arch Otorhinolaryngol. 2011 Oct;268(10):1501-4.

20.  Wei CH, Harari A. Parathyroid carcinoma: update and guidelines for management. Curr Treat Options Oncol. 2012 Mar;13(1):11-23.

21.  Dudney WC, Bodenner D, Stack BC Jr. Parathyroid carcinoma. Otolaryngol Clin North Am. 2010 Apr;43(2):441-53.

22.  Fang SH, Lal G. Parathyroid cancer. Endocr Pract. 2011 Mar-Apr;17 (Suppl 1):36-43.

23.  Ruda JM, Hollenbeak CS, Stack BC Jr. A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003. Otolaryngol Head Neck Surg. 2005 Mar;132(3):359-72.

24.  Kim TY, Kim WB, Gong G, et al. Metastasis to the thyroid diagnosed by fine-needle aspiration biopsy. Clin Endocrinol (Oxf). 2005 Feb;62(2):236-41.

25.  Francis GL, Waguespack SG, Bauer AJ, et al. Management guidelines for children with thyroid nodules and differentiated thyroid cancer. Thyroid. 2015 Jul;25(7):716-59.

26.  Gharib H, Papini E, Garber JR, et al.; American Association of Clinical Endocrinologists, American College of Endocrinology, Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules - 2016 update. Endocr Pract. 2016 May;22(5):622-39.

27.  Frates MC, Benson CB, Doubilet PM, et al. Prevalence and distribution of carcinoma in patients with solitary and multiple thyroid nodules on sonography. J Clin Endocrinol Metab. 2006 Sep;91(9):3411-7.

28.  McCoy KL, Jabbour N, Ogilvie JB, et al. The incidence of cancer and rate of false-negative cytology in thyroid nodules greater than or equal to 4 cm in size. Surgery. 2007 Dec;142(6):837-44.

29.  Englum BR, Pura J, Reed SD, et al. A bedside risk calculator to preoperatively distinguish follicular thyroid carcinoma from follicular variant of papillary thyroid carcinoma. World J Surg. 2015 Dec;39(12):2928-34.

30.  Ito Y, Miyauchi A, Oda H, et al. Revisiting low-risk thyroid papillary microcarcinomas resected without observation: was immediate surgery necessary? World J Surg. 2016 Mar;40(3):523-8.

31.  Hegedüs L. Clinical practice: the thyroid nodule. N Engl J Med. 2004 Oct 21;351(17):1764-71.

32.  Pynnonen MA, Gillespie MB, Roman B, et al. Clinical practice guideline: evaluation of the neck mass in adults. Otolaryngol Head Neck Surg. 2017 Sep;157(2 Suppl):S1-30.

33.  Cases JA, Surks MI. The changing role of scintigraphy in the evaluation of thyroid nodules. Semin Nucl Med. 2000 Apr;30(2):81-7.

34.  Khalid AN, Hollenbeak CS, Quraishi SA, et al. The cost-effectiveness of iodine 131 scintigraphy, ultrasonography, and fine-needle aspiration biopsy in the initial diagnosis of solitary thyroid nodules. Arch Otolaryngol Head Neck Surg. 2006 Mar;132(3):244-50.

35.  Hales NW, Krempl GA, Medina JE. Is there a role for fluorodeoxyglucose positron emission tomography/computed tomography in cytologically indeterminate thyroid nodules? Am J Otolaryngol. 2008 Mar-Apr;29(2):113-8.

36.  Razfar A, Branstetter BF 4th, Christopoulos A, et al. Clinical usefulness of positron emission tomography-computed tomography in recurrent thyroid carcinoma. Arch Otolaryngol Head Neck Surg. 2010 Feb;136(2):120-5.

37.  Boeckmann J, Bartel T, Siegel E, et al. Can the pathology of a thyroid nodule be determined by positron emission tomography uptake? Otolaryngol Head Neck Surg. 2012 Jun;146(6):906-12.

38.  Polyzos SA, Anastasilakis AD. Clinical complications following thyroid fine-needle biopsy: a systematic review. Clin Endocrinol (Oxf). 2009 Aug;71(2):157-65.

39.  Gharib H, Papini E. Thyroid nodules: clinical importance, assessment, and treatment. Endocrinol Metab Clin North Am. 2007 Sep;36(3):707-35.

40.  Cesur M, Corapcioglu D, Bulut S, et al. Comparison of palpation-guided fine-needle aspiration biopsy to ultrasound-guided fine-needle aspiration biopsy in the evaluation of thyroid nodules. Thyroid. 2006 Jun;16(6):555-61.

41.  Theoharis CG, Schofield KM, Hammers L, et al. The Bethesda thyroid fine-needle aspiration classification system: year 1 at an academic institution. Thyroid. 2009 Nov;19(11):1215-23.

42.  Jo VY, Stelow EB, Dustin SM, et al. Malignancy risk for fine-needle aspiration of thyroid lesions according to the Bethesda system for reporting thyroid cytopathology. Am J Clin Pathol. 2010 Sep;134(3):450-6.

43.  Bumpous J, Celestre MD, Pribitkin E, et al. Decision making for diagnosis and management: algorithms from experts for molecular testing. Otolaryngol Clin North Am. 2014 Aug;47(4):609-23.

44.  Alexander EK, Heering JP, Benson CB, et al. Assessment of nondiagnostic ultrasound-guided fine needle aspirations of thyroid nodules. J Clin Endocrinol Metab. 2002 Nov;87(11):4924-7.

45.  Chehade JM, Silverberg AB, Kim J, et al. Role of repeated fine-needle aspiration of thyroid nodules with benign cytologic features. Endocr Pract. 2001 Jul-Aug;7(4):237-43.

46.  Baloch ZW, Cibas ES, Clark DP, et al. The National Cancer Institute Thyroid fine needle aspiration state of the science conference: a summation. Cytojournal. 2008 Apr 7;5:6.

47.  British Thyroid Association. Guidelines for the management of thyroid cancer. July 2014 [internet publication].

48.  Nikiforov YE, Nikiforova MN. Molecular genetics and diagnosis of thyroid cancer. Nat Rev Endocrinol. 2011 Aug 30;7(10):569-80.

49.  Nikiforov YE, Ohori NP, Hodak SP, et al. Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: a prospective analysis of 1056 FNA samples. J Clin Endocrinol Metab. 2011 Nov;96(11):3390-7.

50.  Henrichsen TL, Reading CC. Thyroid ultrasonography. Part 2: nodules. Radiol Clin North Am. 2011 May;49(3):417-24.

51.  Nguyen GK, Lee MW, Ginsberg J, et al. Fine-needle aspiration of the thyroid: an overview. Cytojournal. 2005 Jun 29;2(1):12.

52.  Schneider AB, Sarne DH. Long-term risks for thyroid cancer and other neoplasms after exposure to radiation. Nat Clin Pract Endocrinol Metab. 2005 Dec;1(2):82-91.

53.  De Nicola H, Szejnfeld J, Logullo AF, et al. Flow pattern and vascular resistive index as predictors of malignancy risk in thyroid follicular neoplasms. J Ultrasound Med. 2005 Jul;24(7):897-904.

54.  Wong KT, Ahuja AT. Ultrasound of thyroid cancer. Cancer Imaging. 2005 Dec 9;5:157-66.

55.  Takashima S, Morimoto S, Ikezoe J, et al. CT evaluation of anaplastic thyroid carcinoma. AJR Am J Roentgenol. 1990 May;154(5):1079-85.

56.  Thieblemont C, Mayer A, Dumontet C, et al. Primary thyroid lymphoma is a heterogeneous disease. J Clin Endocrinol Metab. 2002 Jan;87(1):105-11.

57.  Pedersen IB, Knudsen N, Perrild H, et al. TSH-receptor antibody measurement for differentiation of hyperthyroidism into Graves' disease and multinodular toxic goitre: a comparison of two competitive binding assays. Clin Endocrinol (Oxf). 2001 Sep;55(3):381-90.

58.  Huppert BJ, Reading CC. Parathyroid sonography: imaging and intervention. J Clin Ultrasound. 2007 Mar-Apr;35(3):144-55.

59.  Digonnet A, Carlier A, Willemse E, et al. Parathyroid carcinoma: a review with three illustrative cases. J Cancer. 2011;2:532-7.

使用此内容应接受我们的免责声明